Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

scientific workplaces present design challenges when also seeking to create a desirable work environment to attract and ...

Imagine using artificial intelligence to compare two seemingly unrelated creations—biological tissue and Beethoven's ...

The walkthrough mockup is one of the first artifacts of the Gateway platform to go on display.

Telecoms tech business Filtronic has announced plans to launch a new base in the South ... Now the firm has announced it is ...

While Starship has garnered significant attention, leading many to assume that the United States — primarily through SpaceX — ...

BIO aims to use blockchain technology to change how early-stage scientific research is financed and commercialized.